Dunlu Chen

Statistics

Publications

Citations

148

H-Index

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Dunlu Chen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, lipid metabolism, and triglyceride metabolism.

Publications per year

2011–2015

Publications

The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species

David G. McLaren, Timothy He, Sheng-Ping Wang et al. · Journal of Lipid Research · 2011 · 35 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release—Potential insight into mechanism of action

Jinqi Liu, Judith N. Gorski, Stephen J. Gold et al. · Obesity · 2013 · 28 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitors

Hong C. Shen, Fa‐Xiang Ding, Changyou Zhou et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Diacylglycerol Acyltransferase-1 (DGAT1) Inhibition Perturbs Postprandial Gut Hormone Release

Hua Lin, Dunlu Chen, Zhu Shen et al. · PLoS ONE · 2013 · 17 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors

Thomas H. Graham, Hong C. Shen, Wensheng Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6

1–5 of 8